and just to clarify, when I say that "I don't know how many 2b clinical trials in CKD are running or planned at the moment" I am referring to biotech and big pharma around the world...DXB, sitting on <$20M market cap and running 2 trials targeting separate CKD diagnosis has to attract some attention in the right places.
and just to clarify, when I say that "I don't know how many 2b...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.005(1.37%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 36.0¢ | $870.7K | 2.355M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 107188 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 4504 | 1 |
View Market Depth
| Last trade - 16.10pm 04/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |